Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bone Marrow Stimulating”

82 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 82 results

Post-approval studies (Phase 4)Study completedNCT03598582
What this trial is testing

Biological Predictive Factors of Response to ESA in Low Risk MDS Patients

Who this might be right for
Myelodysplastic Syndromes
Association pour la recherche sur les Affections Malignes en Immunologie Sanguine 70
Testing effectiveness (Phase 2)Study completedNCT00135928
What this trial is testing

Stem Cells in Myocardial Infarction

Who this might be right for
Acute Myocardial Infarction
Rigshospitalet, Denmark 78
Testing effectiveness (Phase 2)Study completedNCT01302171
What this trial is testing

Bone Marrow Derived Adult Stem Cells for Dilated Cardiomyopathy

Who this might be right for
Dilated Cardiomyopathy
Barts & The London NHS Trust 60
Not applicableApproved For MarketingNCT05937568
What this trial is testing

Expanded Access for Treatment With Imetelstat

Who this might be right for
Myelodysplastic Syndromes
Geron Corporation
Early research (Phase 1)Study completedNCT00233961
What this trial is testing

G-CSF in Stimulating Peripheral Stem Cells for Autologous Stem Cell Transplant in Treating Patients With Chronic Phase Chronic Myeloid Leukemia in Complete Remission

Who this might be right for
Leukemia
Herbert Irving Comprehensive Cancer Center 20
Large-scale testing (Phase 3)Study completedNCT02993510
What this trial is testing

Controlled Trial Comparing Chondro-Gide® to Microfracture Alone for Treatment of Knee Cartilage Defects.

Who this might be right for
Cartilage InjuryOsteochondritis Dissecans
Geistlich Pharma AG 67
Not applicableStudy completedNCT00053157
What this trial is testing

Sargramostim in Reducing Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplantation for Hematologic Cancer or Aplastic Anemia

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+3 more
Roswell Park Cancer Institute 10
Early research (Phase 1)Study completedNCT00374933
What this trial is testing

Enhancing Graft vs Leukemia Via Delayed Ex-Vivo Co-Stimulated DLI After Non-Myeloablative Stem Cell Transplantation

Who this might be right for
Acute Myelogenous LeukemiaAcute Lymphoblastic LeukemiaMyelodysplastic Syndrome
Abramson Cancer Center at Penn Medicine 18
Not applicableEnded earlyNCT01546337
What this trial is testing

Search for Predictive Markers of Efficacy of ESAs in Patients With Non-myeloid Malignancies or Myelodysplastic Syndrome

Who this might be right for
Myelodysplastic SyndromesAnemiaHemopathies
Rennes University Hospital 30
Post-approval studies (Phase 4)Study completedNCT00126100
What this trial is testing

Bone Marrow Stem Cell Mobilisation Therapy for Acute Myocardial Infarction (AMI)(REVIVAL-2)

Who this might be right for
Myocardial Infarction
Deutsches Herzzentrum Muenchen 114
Large-scale testing (Phase 3)Ended earlyNCT01987596
What this trial is testing

Study of Fixed vs. Flexible Filgrastim to Accelerate Bone Marrow Recovery After Chemotherapy in Children With Cancer

Who this might be right for
Childhood Choroid Plexus TumorChildhood MedulloblastomaChildhood Pineoblastoma+8 more
Barbara Ann Karmanos Cancer Institute 23
Large-scale testing (Phase 3)Active Not RecruitingNCT02598661
What this trial is testing

Study to Evaluate Imetelstat (GRN163L) in Participants With International Prognostic Scoring System (IPSS) Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)

Who this might be right for
Myelodysplastic Syndromes
Geron Corporation 289
Testing effectiveness (Phase 2)Ended earlyNCT00002778
What this trial is testing

Sargramostim Following Allogeneic Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 40
Large-scale testing (Phase 3)Active Not RecruitingNCT03682536
What this trial is testing

Compare the Efficacy and Safety of Luspatercept (ACE-536) Versus Epoetin Alfa for the Treatment of Anemia Due to IPSS-R Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Participants Who Require Red Blood Cell Transfusions and Are ESA Naïve

Who this might be right for
Myelodysplastic Syndromes
Celgene 363
Testing effectiveness (Phase 2)Active Not RecruitingNCT04798339
What this trial is testing

Canakinumab With Darbepoetin Alfa in PTs With Lower-Risk MDS Who Have Failed ESA

Who this might be right for
Myelodysplastic Syndromes
H. Lee Moffitt Cancer Center and Research Institute 13
Testing effectiveness (Phase 2)Ended earlyNCT02093429
What this trial is testing

Randomized Open-Label Study of INCB047986 in Subjects With Primary Myelodysplastic Syndrome (MDS)

Who this might be right for
MDS (Myelodysplastic Syndrome)
Incyte Corporation 6
Testing effectiveness (Phase 2)Study completedNCT04477616
What this trial is testing

Injection Regimen Trial of PEG-rhG-CSF During Breast Cancer Chemotherapy

Who this might be right for
Breast Cancer
The First Affiliated Hospital with Nanjing Medical University 160
Testing effectiveness (Phase 2)UnknownNCT04997811
What this trial is testing

Repurposed Drugs to Improve Haematological Responses in Myelodysplastic Syndromes

Who this might be right for
Myelodysplastic Syndromes (MDS)
Prof. Janet Dunn 120
Testing effectiveness (Phase 2)Active Not RecruitingNCT01757626
What this trial is testing

Combination Therapy of Antibody Hu3F8 With Granulocyte- Macrophage Colony Stimulating Factor (GM-CSF) in Patients With Relapsed/Refractory High-Risk Neuroblastoma

Who this might be right for
Neuroblastoma
Memorial Sloan Kettering Cancer Center 186
Large-scale testing (Phase 3)Study completedNCT01381809
What this trial is testing

An Efficacy Study for Epoetin Alfa in Anemic Patients With Myelodysplastic Syndromes

Who this might be right for
Myelodysplastic Syndromes
Janssen-Cilag International NV 130
Load More Results